Patents by Inventor Samantha Truex

Samantha Truex has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Factor IX Polypeptides and Methods of Use Thereof
    Publication number: 20160346365
    Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
    Type: Application
    Filed: February 12, 2016
    Publication date: December 1, 2016
    Applicant: Biogen Hemophilia Inc.
    Inventors: Glenn PIERCE, Samantha Truex, Robert T. Peters, Haiyan Jiang
  • Factor IX Polypeptides and Methods of Use Thereof
    Publication number: 20160257943
    Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
    Type: Application
    Filed: December 29, 2015
    Publication date: September 8, 2016
    Inventors: Glenn Pierce, Samantha Truex, Robert T. Peters, Haiyan Jiang
  • Factor IX Polypeptides and Methods of Use Thereof
    Publication number: 20160243206
    Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
    Type: Application
    Filed: February 12, 2016
    Publication date: August 25, 2016
    Applicant: Biogen Hemophilia Inc.
    Inventors: Glenn PIERCE, Samantha Truex, Robert T. Peters, Haiyan Jiang
  • Factor IX Polypeptides and Methods of Use Thereof
    Publication number: 20160166657
    Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
    Type: Application
    Filed: February 12, 2016
    Publication date: June 16, 2016
    Applicant: Biogen Hemophilia Inc.
    Inventors: Glenn PIERCE, Samantha Truex, Robert T. Peters, Haiyan Jiang
  • Factor IX polypeptides and methods of use thereof
    Patent number: 9233145
    Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: January 12, 2016
    Assignee: Biogen Hemophila Inc.
    Inventors: Glenn Pierce, Samantha Truex, Robert T. Peters, Haiyan Jiang
  • Methods of Using FIX Polypeptides
    Publication number: 20150252345
    Abstract: The present invention provides methods of administering long-acting Factor IX; methods of administering long-acting, chimeric and hybrid polypeptides comprising Factor IX; and methods of producing such chimeric and hybrid polypeptides using cells.
    Type: Application
    Filed: September 25, 2013
    Publication date: September 10, 2015
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Glenn Pierce, Samantha Truex, Robert T. Peters, Haiyan Jiang, Mark Brader
  • Factor IX Polypeptides and Methods of Use Thereof
    Publication number: 20130202595
    Abstract: The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
    Type: Application
    Filed: July 11, 2011
    Publication date: August 8, 2013
    Applicant: Biogen Idec Hemophilia Inc.
    Inventors: Glenn Pierce, Samantha Truex, Robert T. Peters, Haiyan Jiang